‘Pseudo-Pharmas’ Are Getting Bigger … and Getting Creative When It Comes to Pricing
Shares:
Programming Note: Cost Curve is off tomorrow, back Monday. If you’re looking to get a value fix, though, the Drug Channels webinar on 340B is tomorrow. The topic couldn’t be
In the newsletter earlier today, I mentioned that I was looking for your collective wisdom on how to handle 2025. The link to the survey is now live, and I
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv